Inflation Reduction Act Changes to Part D Plan Design: Lower Premiums, Higher Deductibles, and Some Smaller Formularies

Anderson DM, McEnany M, Petry SE, Anderson KE - Health Affairs

  • Price, Value, and Access

Summary:

Following the redesign of Medicare Part D under the Inflation Reduction Act, actual deductibles were higher than predicted based on 2021-2024 trends for both MA-PD plans ($305 vs. $188) and standalone Part D plans ($491 vs. $401). By contrast, premiums were lower than predicted, and Part D plan formularies shrank for protected classes and lower-cost-sharing tiers with no changes in prior authorization, step therapy, or preferred pharmacy network size. The authors conclude that insurers responded to the increased risk-bearing obligations from the Part D redesign primarily by raising deductibles rather than through utilization management or network restrictions, and they call for continued monitoring as the Premium Stabilization Demonstration expires in 2027.

VIEW SOURCE

Recent Work from PORTAL

Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Pharmaceutical Industry Pay-Per-Click Advertising Strategies to Influence Public Opinions on Drug Pricing

Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics

  • Price, Value, and Access
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Coverage and Costs for Medications After Medicare Price Negotiation

Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine

  • Price, Value, and Access
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Methodological Divergence in Oncology HTA: Implications for International Harmonization and the Handling of Uncertainty

Chen NC, Bullement A, Zemplenyi AT, O'Bryant CL, Kaizer AM, Anderson KE, McQueen RB - PharmacoEconomics Open

  • Price, Value, and Access